Effects of chronic obesity and weight loss on plasma ghrelin and leptin concentrations in dogs. 2005

Isabelle C Jeusette, and Johanne Detilleux, and Haruki Shibata, and Masayuki Saito, and Tsutomu Honjoh, and Agathe Delobel, and Louis Istasse, and Marianne Diez
Affinity-Petcare, 08174, Barcelona, Spain.

The objective of this study was to evaluate, in dogs, the effects of obesity and weight loss on plasma total ghrelin and leptin concentrations. Twenty-four Beagle dogs, 12 control lean and 12 obese dogs of both genders and aged between 1 and 9 years, were used for the experiments. Mean body weight was 12.7+/-0.7 kg for the lean group and 21.9+/-0.8 kg for the obese group. The trial was divided into three phases. During phase 1, all 24 Beagle dogs were fed a maintenance diet. During phase 2, the obese dogs were submitted to a weight loss protocol with a high protein-low energy diet. The weight loss protocol ended once dogs reached optimal body weight. During phase 3, the dogs that were submitted to the weight loss protocol were maintained at their optimal body weight for 6 months. Plasma total ghrelin, leptin, insulin and glucose concentrations were measured to evaluate the effects of obesity and weight loss on these parameters in dogs. Body weight, body condition score, thoracic and pelvic perimeters, and ingested food amounts were also recorded during the study. Obese dogs demonstrated a significant decrease in plasma ghrelin and a significant increase in plasma leptin and insulin concentrations when compared with control dogs. During weight loss, significant increases in plasma total ghrelin and glucose and significant decreases in plasma leptin and insulin were observed. The increase in plasma ghrelin concentrations seemed to be transient. Body weight and the morphometric parameters correlated positively with leptin concentrations and negatively with total ghrelin concentrations. These results suggest that ghrelin and leptin could play a role in dogs in the adaptation to a positive or negative energy balance, as observed in humans.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D004283 Dog Diseases Diseases of the domestic dog (Canis familiaris). This term does not include diseases of wild dogs, WOLVES; FOXES; and other Canidae for which the heading CARNIVORA is used. Canine Diseases,Canine Disease,Disease, Canine,Disease, Dog,Diseases, Canine,Diseases, Dog,Dog Disease
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015431 Weight Loss Decrease in existing BODY WEIGHT. Weight Reduction,Loss, Weight,Losses, Weight,Reduction, Weight,Reductions, Weight,Weight Losses,Weight Reductions
D054439 Ghrelin A 28-amino acid, acylated, orexigenic peptide that is a ligand for GROWTH HORMONE SECRETAGOGUE RECEPTORS. Ghrelin is widely expressed but primarily in the stomach in the adults. Ghrelin acts centrally to stimulate growth hormone secretion and food intake, and peripherally to regulate energy homeostasis. Its large precursor protein, known as appetite-regulating hormone or motilin-related peptide, contains ghrelin and obestatin. Appetite-Regulating Hormone,GHRL Protein,Gastric MLTRP,Ghrelin Precursor,Ghrelin-Obestatin Preprohormone,Motilin-Related Peptide,Motilin-Related Peptide Precursor,Obestatin,PpMTLRP,Ppghrelin,Appetite Regulating Hormone,Ghrelin Obestatin Preprohormone,Motilin Related Peptide,Motilin Related Peptide Precursor,Peptide Precursor, Motilin-Related,Precursor, Ghrelin,Precursor, Motilin-Related Peptide

Related Publications

Isabelle C Jeusette, and Johanne Detilleux, and Haruki Shibata, and Masayuki Saito, and Tsutomu Honjoh, and Agathe Delobel, and Louis Istasse, and Marianne Diez
April 2010, Acta neurologica Scandinavica,
Isabelle C Jeusette, and Johanne Detilleux, and Haruki Shibata, and Masayuki Saito, and Tsutomu Honjoh, and Agathe Delobel, and Louis Istasse, and Marianne Diez
October 2013, Veterinary journal (London, England : 1997),
Isabelle C Jeusette, and Johanne Detilleux, and Haruki Shibata, and Masayuki Saito, and Tsutomu Honjoh, and Agathe Delobel, and Louis Istasse, and Marianne Diez
March 2009, European journal of nutrition,
Isabelle C Jeusette, and Johanne Detilleux, and Haruki Shibata, and Masayuki Saito, and Tsutomu Honjoh, and Agathe Delobel, and Louis Istasse, and Marianne Diez
March 2023, Obesity (Silver Spring, Md.),
Isabelle C Jeusette, and Johanne Detilleux, and Haruki Shibata, and Masayuki Saito, and Tsutomu Honjoh, and Agathe Delobel, and Louis Istasse, and Marianne Diez
November 1997, The Journal of clinical endocrinology and metabolism,
Isabelle C Jeusette, and Johanne Detilleux, and Haruki Shibata, and Masayuki Saito, and Tsutomu Honjoh, and Agathe Delobel, and Louis Istasse, and Marianne Diez
March 2008, Critical care medicine,
Isabelle C Jeusette, and Johanne Detilleux, and Haruki Shibata, and Masayuki Saito, and Tsutomu Honjoh, and Agathe Delobel, and Louis Istasse, and Marianne Diez
October 2002, The New England journal of medicine,
Isabelle C Jeusette, and Johanne Detilleux, and Haruki Shibata, and Masayuki Saito, and Tsutomu Honjoh, and Agathe Delobel, and Louis Istasse, and Marianne Diez
October 2002, The New England journal of medicine,
Isabelle C Jeusette, and Johanne Detilleux, and Haruki Shibata, and Masayuki Saito, and Tsutomu Honjoh, and Agathe Delobel, and Louis Istasse, and Marianne Diez
October 2002, The New England journal of medicine,
Isabelle C Jeusette, and Johanne Detilleux, and Haruki Shibata, and Masayuki Saito, and Tsutomu Honjoh, and Agathe Delobel, and Louis Istasse, and Marianne Diez
September 2006, American journal of veterinary research,
Copied contents to your clipboard!